Medicare Rx Law Would Fundamentally Change, Not End, Drug Pricing Debate
Executive Summary
A House proposal to fund federal cost-effectiveness trials of pharmaceuticals may be a sign of things to come if the Medicare prescription drug legislation is enacted this year
You may also be interested in...
Follow-On Biologics Law “Inevitable,” Sen. Hatch Says; BIO Must “Engage”
Legislation creating a follow-on biologics approval pathway is inevitable, Sen. Orrin Hatch (R-Utah) said at the conclusion of a June 23 Judiciary Committee hearing
Follow-On Biologics Law “Inevitable,” Sen. Hatch Says; BIO Must “Engage”
Legislation creating a follow-on biologics approval pathway is inevitable, Sen. Orrin Hatch (R-Utah) said at the conclusion of a June 23 Judiciary Committee hearing
Senate Medicare Bill Directs GAO To Study International Price Controls
The Senate Medicare legislation would direct the General Accounting Office to produce a study of international price controls within one year of enactment